Statewide
Tennessee Emergency Medical Services
Tennessee Emergency Medical Services (TN) carries 42 drugs across 143 dose entries in its current published protocol, effective 2024-01-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses42
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 325–1000 mg | PO | not captured | standing | page 143 · source |
| Other | peds | 10–15 mg/kg | PO | not captured | standing | page 143 · source |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 12 mg | IV | not captured | standing | pages 22, 27 · source |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 22, 27 · source |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2.5 mg | NEB | not captured | standing | page 45 · source |
| Crush injury | adult | 5 mg | NEB | not captured | standing | page 139 · source |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | pages 59, 210 · source |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | pages 59, 210 · source |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV | not captured | standing | page 28 · source |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 28 · source |
| Wide-complex tachycardia | adult | 150–300 mg | IV/IO | not captured | standing | pages 21, 27 · source |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 21, 27 · source |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 25 · source |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 25 · source |
Amyl Nitrite
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 ampule | NEB | not captured | standing | page 132 · source |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 16, 18 · source |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV | not captured | standing | page 15 · source |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 15 · source |
| Nerve agent exposure | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 39 · source |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 g | IV | not captured | standing | page 140 · source |
| Crush injury | peds | 20 mg/kg | IV | not captured | standing | page 140 · source |
| Hyperkalemia | adult | 500 mg | IV | not captured | standing | pages 20, 24, 25 · source |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | pages 20, 24, 25 · source |
| Tricyclic overdose | adult | 500 mg | IV | not captured | standing | pages 20, 24, 25 · source |
| Tricyclic overdose | peds | 20 mg/kg | IV | not captured | standing | pages 20, 24, 25 · source |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 g | TOP | not captured | standing | page 130 · source |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 25 g | IV | not captured | standing | page 139 · source |
| Crush injury | peds | 0.5 g/kg | IV | not captured | standing | page 139 · source |
| Hypoglycemia | adult | 12.5–25 g | IV | not captured | standing | pages 56, 64, 204, 210, 211 · source |
| Hypoglycemia | peds | 2 mL/kg | IV | not captured | standing | pages 56, 64, 204, 210, 211 · source |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | peds | 0.1 mg/kg | IV | not captured | standing | page 40 · source |
| Procedural sedation | adult | 2–5 mg | IV | not captured | standing | pages 22, 23, 27 · source |
| Procedural sedation | peds | 0.1 mg/kg | IV | not captured | standing | pages 22, 23, 27 · source |
| Seizure | adult | 2–5 mg | IV/IO | not captured | standing | pages 31, 32, 39, 60, 61 · source |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 31, 32, 39, 60, 61 · source |
| Seizure | peds | 0.2–0.5 mg/kg | PR | not captured | standing | page 61 · source |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 148 · source |
Dimercaprol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 3 mg/kg | IM | not captured | standing | page 128 · source |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | IV/IM | not captured | standing | pages 46, 210 · source |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | pages 46, 210 · source |
| Dystonic reaction | adult | 25 mg | IV/IM | not captured | standing | page 121 · source |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | page 146 · source |
| Nausea / vomiting | adult | 0.625–2.5 mg | IV/IM | not captured | standing | page 146 · source |
| Nausea / vomiting | peds | 0.015–0.1 mg/kg | IV/IM | not captured | standing | page 146 · source |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 46 · source |
| Anaphylaxis | adult | 0.3–0.5 mg | IV/IO | not captured | standing | page 46 · source |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 46 · source |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 46 · source |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | page 15 · source |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 15, 20, 24, 25, 26 · source |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 15, 20, 24, 25, 26 · source |
| Croup | peds | 1 mg | NEB | not captured | standing | pages 50, 210 · source |
| Respiratory distress | adult | 0.3–0.5 mg | IM | not captured | standing | page 59 · source |
| Respiratory distress | peds | 0.01 mg/kg | IM | not captured | standing | page 59 · source |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 mg | IV/IM | not captured | standing | page 15 · source |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5–1 mg | IV/IM | not captured | standing | page 15 · source |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | pages 60, 64 · source |
| Hypoglycemia | peds | 0.5–1 mg | IM | not captured | standing | pages 60, 64 · source |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | page 147 · source |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 126, 144 · source |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 400–800 mg | PO | not captured | standing | page 142 · source |
| Other | adult | 600 mg | PO | not captured | standing | page 160 · source |
| Other | peds | 10 mg/kg | PO | not captured | standing | page 160 · source |
| Other | peds | 5–10 mg/kg | PO | not captured | standing | page 142 · source |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 10 unit | IV | not captured | standing | page 139 · source |
| Crush injury | peds | 0.2 unit/kg | IV | not captured | standing | page 139 · source |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1.5–2 mg/kg | IV | not captured | standing | page 205 · source |
| Agitation | peds | 1.5–2 mg/kg | IV | not captured | standing | page 205 · source |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 206 · source |
| RSI induction | peds | 1–2 mg/kg | IV | not captured | standing | page 206 · source |
| Seizure | adult | 1 mg/kg | IV/IM | not captured | standing | page 206 · source |
| Seizure | peds | 1 mg/kg | IV/IM | not captured | standing | page 206 · source |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 10–30 mg | IV/IM | not captured | standing | page 143 · source |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 141 · source |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 141 · source |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 141 · source |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 141 · source |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 1–2 mg | IV | not captured | standing | pages 31, 32, 39, 60, 61 · source |
| Seizure | adult | 2–4 mg | IM | not captured | standing | pages 31, 39, 60 · source |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | pages 31, 32, 39, 60, 61 · source |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 g | IV | not captured | standing | page 98 · source |
| Respiratory distress | adult | 1–2 g | IV | not captured | standing | page 59 · source |
| VF / pulseless VT | adult | 1–2 g | IV | not captured | standing | pages 23, 24, 25 · source |
Methylene Blue
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg/kg | IV | not captured | standing | page 136 · source |
Methylergonovine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 0.2 mg | IM | not captured | standing | page 91 · source |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 62.5–125 mg | IV | not captured | standing | pages 46, 211 · source |
| Respiratory distress | adult | 62.5–125 mg | IV | not captured | standing | pages 59, 211 · source |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | not captured | not captured | standing | pages 114, 117 · source |
| Agitation | peds | 0.1 mg/kg | not captured | not captured | standing | pages 114, 117 · source |
| Agitation | peds | 0.1 mg/kg | IV | not captured | standing | page 40 · source |
| Procedural sedation | adult | 2–5 mg | IV | not captured | standing | pages 22, 23, 27 · source |
| Procedural sedation | peds | 0.1 mg/kg | IV | not captured | standing | pages 22, 23, 27 · source |
| Seizure | adult | 2–5 mg | IV/IO/IM | not captured | standing | pages 31, 39, 60 · source |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 32, 39, 61 · source |
| Seizure | peds | 0.3 mg/kg | IN | not captured | standing | pages 32, 39, 61 · source |
Misoprostol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 400 mcg | PR | not captured | standing | page 91 · source |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.4–2 mg | IV/IN | not captured | standing | page 14 · source |
| Cardiac arrest | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 20 · source |
| Hypothermia | adult | 0.4 mg | IV/IO/IM/IN | not captured | standing | page 35 · source |
| Hypothermia | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 35 · source |
| Opioid overdose | adult | 0.4 mg | IV/IN | not captured | standing | page 167 · source |
| Opioid overdose | peds | 0.1 mg/kg | IV/IN | not captured | standing | page 167 · source |
| Other | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | page 31 · source |
| Other | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | page 64 · source |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 31 · source |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 64 · source |
| Seizure | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | page 60 · source |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 60 · source |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 kit | IM | not captured | standing | page 38 · source |
| Other | adult | 1 kit | IM | not captured | standing | page 138 · source |
| Other | adult | 3 kits | IM | not captured | standing | page 38 · source |
| Other | adult | 3 kits | IM | not captured | standing | page 138 · source |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 16, 17, 18 · source |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 45 · source |
| Other | adult | 0.4 mg | SL | not captured | standing | page 55 · source |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 2–4 mg | IV | not captured | standing | pages 44, 211 · source |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | page 44 · source |
| Nausea / vomiting | peds | 0.15 mg/kg | IV | not captured | standing | pages 44, 211 · source |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | page 44 · source |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 tube | PO | not captured | standing | page 56 · source |
| Hypoglycemia | peds | 1 tube | PO | not captured | standing | page 56 · source |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 91 · source |
| Obstetric hemorrhage | adult | 30–40 unit | IV | not captured | standing | page 91 · source |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 600 mg | IV | not captured | standing | page 138 · source |
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | page 138 · source |
| Organophosphate poisoning | peds | 15 mg/kg | IV | not captured | standing | page 138 · source |
| Organophosphate poisoning | peds | 15 mg/kg | IM | not captured | standing | page 138 · source |
| Other | adult | 20–50 mg/kg | IV | not captured | standing | page 138 · source |
| Other | adult | 600 mg | IM | not captured | standing | page 138 · source |
| Other | peds | 15 mg/kg | IM | not captured | standing | page 138 · source |
| Other | peds | 20–50 mg/kg | IV | not captured | standing | page 138 · source |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV | not captured | standing | page 139 · source |
| Crush injury | peds | 1 mEq/kg | IV | not captured | standing | page 139 · source |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 20, 24, 25 · source |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 20, 24, 25 · source |
| Other | adult | 1–2 mEq/kg | IV/IO | not captured | standing | pages 20, 24, 25 · source |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 20, 24, 25 · source |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 20, 24, 25 · source |
Sodium Nitrite
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV | not captured | standing | page 132 · source |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | not captured | not captured | standing | page 122 · source |
| Other | adult | 2 drop | not captured | not captured | standing | page 134 · source |